Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the sentrant device.The exact size of the device is unknown.Survey results from a vascular surgeon in practice 20 years, who has used the device 400 times in total over the last 3 years and 150 times in the last 12 months.During use of the sentrant, death events were encountered.The physician found the deaths very concerning.One of the death events was considered to be device related.The physician was previously aware that these events were in the ifu.No further information has or will be provided.
|